- Home
- ANGH vs CLGN Comparison
ANGH vs CLGN Comparison
Compare ANGH & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGH
- CLGN
- Stock Information
- Founded
- ANGH 2012
- CLGN 2004
- Country
- ANGH United Arab Emirates
- CLGN Israel
- Employees
- ANGH N/A
- CLGN N/A
- Industry
- ANGH Telecommunications Equipment
- CLGN Industrial Specialties
- Sector
- ANGH Consumer Discretionary
- CLGN Health Care
- Exchange
- ANGH Nasdaq
- CLGN Nasdaq
- Market Cap
- ANGH 52.2M
- CLGN 48.1M
- IPO Year
- ANGH N/A
- CLGN N/A
- Fundamental
- Price
- ANGH $0.70
- CLGN $4.03
- Analyst Decision
- ANGH
- CLGN Strong Buy
- Analyst Count
- ANGH 0
- CLGN 2
- Target Price
- ANGH N/A
- CLGN $12.50
- AVG Volume (30 Days)
- ANGH 50.9K
- CLGN 12.0K
- Earning Date
- ANGH 01-24-2025
- CLGN 11-27-2024
- Dividend Yield
- ANGH N/A
- CLGN N/A
- EPS Growth
- ANGH N/A
- CLGN N/A
- EPS
- ANGH N/A
- CLGN N/A
- Revenue
- ANGH $52,274,011.00
- CLGN $650,000.00
- Revenue This Year
- ANGH N/A
- CLGN N/A
- Revenue Next Year
- ANGH N/A
- CLGN $692.59
- P/E Ratio
- ANGH N/A
- CLGN N/A
- Revenue Growth
- ANGH 13.03
- CLGN N/A
- 52 Week Low
- ANGH $0.62
- CLGN $3.24
- 52 Week High
- ANGH $2.27
- CLGN $6.75
- Technical
- Relative Strength Index (RSI)
- ANGH 43.81
- CLGN 52.27
- Support Level
- ANGH $0.62
- CLGN $3.79
- Resistance Level
- ANGH $0.83
- CLGN $4.31
- Average True Range (ATR)
- ANGH 0.06
- CLGN 0.21
- MACD
- ANGH -0.01
- CLGN 0.02
- Stochastic Oscillator
- ANGH 36.36
- CLGN 54.89
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with the catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner and is continuously licensing new content.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.